Perceptive Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
– Sell
-100,000
Closed -$2.78M – 170
2015
Q3
$2.78M Buy
+100,000
New +$3.61M 0.22% 69
2015
Q2
– Sell
-100,000
Closed -$3.04M – 186
2015
Q1
$3.04M Hold
100,000
– – 0.24% 73
2014
Q4
$1.98M Buy
+100,000
New +$2.24M 0.17% 89
2014
Q2
– Sell
-45,000
Closed -$579K – 136
2014
Q1
$579K Sell
45,000
-120,000
-73% -$1.72M 0.06% 93
2013
Q4
$2.25M Buy
165,000
+96,700
+142% +$1.15M 0.27% 48
2013
Q3
$757K Buy
+68,300
New +$680K 0.06% 77

Other funds holding RGEN

Perceptive Advisors's RGEN Position: Q3 2026 in Review

Perceptive Advisors increased its Repligen (RGEN) stake by 9.8% in Q3 2026, buying an estimated $3.94M and bringing the position to 272,456 shares worth $52.4M. The position accounts for 0.91% of the portfolio, ranked #27.

Perceptive Advisors first reported a position in RGEN in Q3 2017 and has held it in 10 quarters since. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Perceptive Advisors held 272,456 shares of Repligen worth $52.4M as of Q3 2026.
  • Perceptive Advisors bought 24,244 Repligen shares in Q3 2026, an estimated $3.94M.
  • Repligen made up 0.91% of Perceptive Advisors's portfolio in Q3 2026, its #27 holding.
  • Perceptive Advisors first reported a position in Repligen in Q3 2017 and has held it in 10 quarters since.
  • 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Perceptive Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.